These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2574677)

  • 1. Factor requirements for activation and proliferation steps of human CD2+CD3-CD4-CD8- early thymocytes.
    Dalloul AH; Mossalayi MD; Dellagi K; Bertho JM; Debré P
    Eur J Immunol; 1989 Nov; 19(11):1985-90. PubMed ID: 2574677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
    Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
    J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
    Plum J; De Smedt M; Leclercq G
    J Immunol; 1993 Apr; 150(7):2706-16. PubMed ID: 8095954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation.
    Hirokawa M; Gray JD; Takahashi T; Horwitz DA
    J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
    Gerli R; Bertotto A; Crupi S; Arcangeli C; Marinelli I; Spinozzi F; Cernetti C; Angelella P; Rambotti P
    J Immunol; 1989 Apr; 142(8):2583-9. PubMed ID: 2564856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism.
    Hofmann B; Nishanian P; Baldwin RL; Insixiengmay P; Nel A; Fahey JL
    J Immunol; 1990 Dec; 145(11):3699-705. PubMed ID: 1978848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
    Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
    J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation.
    Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL
    J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochalasins enhance the proliferation of CD4 cells through the CD3-Ti antigen receptor complex or the CD2 molecule through an effect on early events of activation.
    Matsuyama T; Yamada A; Deusch K; Sleasman J; Daley JF; Torimoto Y; Abe T
    J Immunol; 1991 Jun; 146(11):3736-41. PubMed ID: 1709660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
    Toribio ML; De la Hera A; Marcos MA; Márquez C; Martínez C
    Eur J Immunol; 1989 Jan; 19(1):9-15. PubMed ID: 2522051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of CD2 during murine thymocyte ontogeny.
    Yagita H; Asakawa J; Tansyo S; Nakamura T; Habu S; Okumura K
    Eur J Immunol; 1989 Dec; 19(12):2211-7. PubMed ID: 2575032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective stimulation of thymocyte precursors mediated by specific cytokines. Different CD3+ subsets are generated by IL-1 versus IL-2.
    Gotlieb WH; Durum SK; Gregorio TA; Mathieson BJ
    J Immunol; 1991 Apr; 146(7):2262-71. PubMed ID: 1706392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation.
    Lorré K; Van Damme J; Ceuppens JL
    Eur J Immunol; 1990 Jul; 20(7):1569-75. PubMed ID: 1974850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the anti-CD3-unresponsive subpopulation of CD4+, CD45RA+ peripheral T lymphocytes.
    Koulova L; Yang SY; Dupont B
    J Immunol; 1990 Oct; 145(7):2035-43. PubMed ID: 1697875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
    Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
    J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of Ca2+ mobilization in human thymocytes by coaggregation of surface molecules.
    Deusch K; Daley JF; Levine H; Languet AJ; Anderson P; Schlossman SF; Blue ML
    J Immunol; 1990 Apr; 144(8):2851-8. PubMed ID: 1691220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.